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Background: Obesity-related diseases have a profound economic impact on health care systems. Laser acupuncture has
been shown to have beneficial effects on obesity. However, to our knowledge, those trials were either non-randomized,
non-blinded or included low-calorie diet control. We have, therefore, designed a patient-assessor-blinded, randomized,
sham-controlled crossover trial to investigate the significance of laser acupuncture on obesity.
Methods/Design: 104 subjects above 20 years of age with a body mass index (BMI) of over 25 kg/m2 will be
divided into 2 groups: experimental and control. Each subject will receive the treatment relevant to their group
3 times a week for 8 weeks. After 8 weeks of treatment the subject will enter a 2-week washout period, after which
the subjects will switch groups. Measurements will include BMI, body fat percentage, waist-to-hip ratio (WHR), waist
circumference, hip circumference, skinfold thickness, thigh circumference, body fat, blood pressure, heart rate, hunger
and the 36-item Short-Form Health Survey (SF-36).
Discussion: The results of this study will provide the basis for future large-scale multicenter trials investigating the
effects of laser acupuncture on obesity.
Trial registration: ClinicalTrials.gov Identifier: NCT02167308; registration date: 14 June 2014.
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The number of obese people around the world has been
increasing rapidly. It has been estimated that over 10%
of the world’s adult population are obese [1]. Obesity is
associated with increased risk of coronary heart disease,
type II diabetes, stroke, osteoarthritis and certain types
of cancer. These deleterious conditions are detrimental
to individuals’ quality of life, and places emotional and
financial burden on the individual, their families and
society as a whole [2]. Much more needs to be done to
improve treatments for obesity.
Current methods to treat obesity include dietary
intervention, lifestyle intervention, drug intervention
or bariatric surgery. Among these, acupuncture, in a
comprehensive program for weight loss, has been in-
creasing in popularity. However, previous systematic* Correspondence: acupmox@hotmail.com
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discovered promising but inconclusive results. The
low-quality methodology used in those trials further
reduced the strength of those conclusions [3, 4]. In
addition, the lack of safety procedures used in trad-
itional manual acupuncture could lead to adverse
events such as retroperitoneal abscess, rapid dermal
spread of breast cancer, pneumothorax, cardiac tam-
ponade, viral hepatitis and granuloma [5].
In comparison with traditional manual acupuncture,
laser acupuncture therapy has several advantages. These
advantages include ease of application, precision in dose
measurement, painlessness and non-invasiveness. It is a
quick and safe therapy with low cost and no risk of in-
fection. As laser acupuncture does not produce local
sensation, double-blind randomized controlled studies
are also much easier to perform.
Laser acupuncture has been widely used in medical
fields for over 30 years. Clinical research on the efficacy
of laser acupuncture has also increased [6, 7]. Several
studies have shown that laser acupuncture could be anThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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apy as a non-invasive approach for body contouring and
spot fat reduction has also been reported [10, 11]. How-
ever, there are several experimental limitations that have
to be considered. For instance, absence of placebo
(sham) control, combination with low-calorie diet and
lack of sufficient comparative parameters have been
questioned [12]. For these reasons, we decided to con-
duct a patient-assessor-blinded, randomized, sham-
controlled crossover pilot trial to investigate the effects
of laser acupuncture with Gallium Aluminum Arsenide
(GaAlAs) laser irradiation on weight loss, fat reduction,
body contouring and quality of life in people suffering
from obesity.
Methods/Design
Aim of the study
The aim of this study is to assess the effectiveness of
laser acupuncture in the treatment of obesity. We will
evaluate whether laser acupuncture changes body mass
index (BMI), body fat percentage, waist-to-hip ratio
(WHR), waist circumference, hip circumference, thigh
circumference, body fat, blood pressure, heart rate, hun-
ger and quality of life. All adverse events will also be
assessed.
Study design
This study proposes a patient-assessor-blinded, random-
ized, sham-controlled crossover trial with a 2-week
washout period between each crossover phase. The trials
will be conducted at the Chiayi Chang Gung Memorial
Hospital. This study will adhere to the recommendations
of the Consolidated Standards of Reporting Trials
(CONSORT) [13] to allow for greater completeness,
transparency and accuracy of reporting. The protocol for
this study has been registered in the Clinical Trials regis-
ter (ClinicalTrials.gov Identifier: NCT02167308).
Subjects who voluntarily sign a consent form will
undergo the trial according to the study design. When a
subject is determined to be fit for participation based on
inclusion and exclusion criteria, the subject will be ran-
domly assigned to 1 of 2 groups in a ratio of 1:1. One
group is the true laser experimental group and the other
is the sham laser control group. Each group will receive
their treatment 3 times a week for 8 weeks. After 8
weeks of treatment and a 2-week washout period, the
control group will switch to the experimental group
while the experimental group will switch to the control
group. The subjects then undergo the treatment of their
new group for another 8 weeks (Fig. 1).
Treatment and assessment will be performed inde-
pendently and the practitioners will not be involved in
assessing the outcome of the treatment. The subjects,
the outcome assessors and the statistician performingthe data analyses will be blinded to the treatment alloca-
tion throughout the study.
Sample size
This study is a pilot study for evaluating the efficacy of
actual laser acupuncture compared to sham laser acu-
puncture, and to evaluate the feasibility of large clinical
trials. In the hopes of decreasing the subject drop-out
rate, the trial is designed to only last 8 weeks. Assuming
a drop-out rate of 10%, the desired sample size for this
pilot study is 104 subjects, with 52 in each group. Based
on the a priori calculation in G*Power 3.1.3 [14] it was
determined that a minimum total sample size of 92
would be needed in a repeated measures between factors
design to show a significant difference (effect size = 0.25;
α = 0.05; 1 – β = 0.8; number of measurements = 8; cor-
relation among repeated measures = 0.2).
Ethics
This research protocol adheres to the principles of the
Declaration of Helsinki and has been approved by the
institutional review boards of the Chang Gung Memorial
Hospital (103-1403A3). Informed consent will be obtained
from each participant before any treatment is given. All
subjects will have the right to withdraw from the study at
any time.
Inclusion criteria
Individuals are eligible if they are above 20 years of age
and have a BMI over 25 kg/m2. BMI cutoffs were
adopted from a proposed classification of weight by BMI
in adult Asians, including the Obese I (BMI: 25 to 29.9
kg/m2) and Obese II (BMI ≥ 30 kg/m2) categories [15].
Exclusion criteria
Individuals are not eligible if they have a medical history
of cardiovascular disease, diabetes, endocrine abnormal-
ities, renal disease, contagious skin condition, epilepsy,
tumors, mental disorders, are pregnant, have photosensi-
tivity reactions to laser treatment, use a pacemaker, have
used medications known to affect one’s weight up to 1
month in advance, or are unwilling to comply with the
study protocol.
Randomization and allocation concealment
After initial assessments, subjects will be assigned to 1
of 2 groups with a 1:1 allocation ratio according to a
computer-generated randomization list. The group
each subject is allocated to will be concealed in
sequentially numbered sealed opaque envelopes. The
envelopes will only be opened after the subject has
completed baseline clinical assessments. Randomization
allocation will be concealed from the physician, subjects
and evaluators.
Fig. 1 Flowchart of the study design
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Laser acupuncture group
Subjects will receive 24 activated laser acupuncture
treatments. Treatments will be performed 3 times a week
for 8 weeks. Based on the theory of Traditional Chinese
Medicine (TCM) and clinical literature on acupuncture
therapy for the obese, the acupoints are as follows: ST25
(Tianshu), ST36 (Zusanli), ST40 (Fenglong), ST44
(Neiting), LI4 (Hegu), LI11 (Quchi), SP6 (Sanyinjiao)
and PC6 (Neiguan). An additional file shows this in
more detail (see Additional file 1).
The treatment will be applied by a GaAlAs semicon-
ductor diode Laser Phototherapy Device (Model: T-816-
3E2-808) developed by Transverse Industries Co., Ltd,
Taipei, Taiwan with a wavelength of 808 nm. Maximum
power output is 150 mW in continuous wave mode at a
power density of 0.417 W/cm2. The laser will be applied
for 10 seconds to each of the selected acupuncture
points with an energy density of 4 J/cm2 for each point.
This is the recommended treatment dose for low-level
laser therapy as documented by the World Association
of Laser Therapy [16, 17].The laser handheld device (Laser Beam Spot Size ≤ 36
mm2) will be applied directly and perpendicularly. There
will be slight contact with the skin surface to avoid scat-
tering the laser beam. Apart from the light touch of the
laser probe when applied to the skin, no sensations were
reported when the device was used in the past.
Control group
Subjects in the control group will undergo sham laser acu-
puncture treatment with no laser power output. Acupunc-
ture points, application duration and total number of
treatments will be identical to the experimental group. All
laser application will be performed by the same physician.
Outcome assessment
Before the treatment, clinical assessment parameters
will be evaluated by an evaluator. Post-treatment assess-
ments will be evaluated by a different evaluator. The
physician who applies the treatment to the subject will
not be involved in assessing the parameters. This way,
the subject and both evaluators will be blinded to the
treatment being performed.
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from baseline. BMI will be calculated using weight (kg)/
height (m2). Secondary outcome measurements include
waist circumference, hip circumference, WHR, body fat
percentage, hunger and a Short-Form 36-item Health
Survey (SF-36). Waist circumference will be measured at
the midpoint between the lower margin of the least
palpable rib and the top of the iliac crest, using a
stretch‐resistant tape. Hip circumference will be mea-
sured around the widest portion of the buttocks, with
the tape parallel to the floor [18]. Bioelectrical imped-
ance will be used to measure the percentage of body fat.
For hunger, a Visual Analog Scale (VAS) with horizon-
tal lines will be used, graded from 0 mm, representing
no hunger, to 100 mm, representing the most extreme
hunger imaginable. Subjects will be asked to mark their
level of hunger on the VAS. Subjects will be prohibited
from accessing their previous VAS records on subse-
quent sessions. Measurements of appetite as expressed
by ratings on the VAS has been shown to be highly re-
producible and reliable for appetite research [19]. These
clinical assessments will be performed before the trials,
once every 2 weeks during the treatment, and 2 months
after the last treatment.
SF-36 is a widely used questionnaire for measuring
self-reported physical and mental health status. Each
subject will answer the SF-36 questionnaire before the
trials, immediately after the trials and 2 months after the
last treatment. The SF-36 questionnaire consists of 11
questions concerning general health, and can be divided
into two aggregate summary measures: the Physical Com-
ponent Summary and the Mental Component Summary.
The SF-36 has become one of the most widely used mea-
sures to evaluate health-related quality of life [20].
Other outcome parameters are skinfold thickness,
thigh circumference, blood pressure and heart rate. Skin-
fold thickness will be measured to the nearest millimeter
at six sites (triceps, subscapular, suprailiac, abdomen,
thigh and calf ) using a caliper [21]. All measurements
will be taken from the right side of the body. These skin-
fold thickness measurements will be taken three times,
with the average of the 3 values recorded as the
representative value. Previous research has indicated that
skinfold caliper and computed tomography are similar
with respect to the measurement of subcutaneous body
fat [22]. The skinfold thickness measurement at different
body sites is important because regional adiposity, rather
than total excess adiposity, has a greater impact on
certain diseases [23].
Follow-up
Follow-up observations will be conducted before the
trials, once every 2 weeks during the treatment, and 2
months after the last treatment.Statistical analysis
Statistical analysis will be performed by using the software
program Statistical Package for the Social Sciences (SPSS
15.0, Chicago, IL, USA). Participants’ demographic in-
formation and levels of major measured variables were
analyzed by descriptive statistics. Means and standard
deviations of the clinical indices will be calculated, after
which the evaluation between the two groups will be
compared using a Student’s t-test. The difference of
evaluation scores before and after each examination
point will be analyzed using paired t-tests. The repeated
measures analysis of variance (ANOVA) will be used to
analyze longitudinal and repeated measured data for the
clinical indices across the 8 data collection points (treat-
ments for 16 weeks, followed-up evaluation biweekly).
A value of P < 0.05 will be regarded as statistically
significant for the above statistical analyses.
Adverse events
Subjects will be asked to report any adverse events they
experience. The evaluator will then interview the sub-
jects to confirm the validity of the adverse event. If these
events occur during treatment, the physician will imme-
diately stop the procedure and treat the adverse event.
The evaluator will then file a report detailing the ser-
iousness of the event, event onset date, relationship be-
tween the event and the treatment, possible causes of
the event other than the trial itself, and other relevant
data. The report will then be sent to the ethics commit-
tee. The ethics committee will then decide whether or
not to modify the study protocol or remove the subject
from the trial.
Discussion
Obesity is closely linked to many serious health prob-
lems and has a profound economic impact on health
care systems and society. Current drug treatments for
obesity are largely inadequate and there is an enor-
mous unmet clinical need for more safe and efficacious
obesity treatments. Laser acupuncture has been shown
to have beneficial effects on obesity. However, to our
knowledge those trials were either non-randomized,
non-blinded, had a limited number of subjects, or
included low-calorie diet control. We have, therefore,
designed a patient-assessor-blinded, randomized, sham-
controlled crossover trial to investigate the effects
of laser acupuncture on obesity. A 1-week washout
period between treatment sessions was used in a
previous randomized crossover study of acupuncture
on obesity [24]. We extended this washout period
to 2 weeks to further reduce potential carryover
effects.
Analysis of skinfold thickness at different body sites,
feeling of hunger and quality of life will also be performed.
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yet been measured in similar studies investigating the ef-
fects of laser acupuncture on obesity. Through this study
we will be able to determine whether or not laser acu-
puncture can alter regional adiposity, body contour and
sense of well-being. We hypothesize that appetite suppres-
sion and circumferential reduction through laser acupunc-
ture can help people achieve better self-control in diet and
exercise. If our hypothesis is correct, laser acupuncture
may play a role in encouraging subjects to adhere to
changes in behavioral lifestyle.
Previous research has suggested that gender moderates
the psychological and behavioral variables on weight loss
treatment [25]. However, the relevance of gender on
weight loss differences with respect to laser acupuncture
remains unexplored. Unlike previous studies, we will
equalize the sample sizes of the two genders to help elu-
cidate this substantial variability in outcomes. This trial
seeks to provide clinical data on the effect of laser acu-
puncture on BMI, body fat, WHR, body contour, appe-
tite and quality of life in the obese. Results of this trial
will help clarify the value of laser acupuncture as a treat-
ment option for individuals suffering from obesity.
Trial status
This trial is currently recruiting participants.
Additional file
Additional file 1: Anatomical locations of the acupuncture points.
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